Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Clinical & Experimental Metastasis
Published in: Clinical & Experimental Metastasis 7/2003

01-11-2003

IL-2-mediated augmentation of NK-cell activity and activation antigen expression on NK- and T-cell subsets in patients with metastatic melanoma treated with interferon-α and DTIC

Authors: Gordana Konjević, Viktor Jović, Vladimir Jurišić, Siniša Radulović, Svetislav Jelić, Ivan Spužić

Published in: Clinical & Experimental Metastasis | Issue 7/2003

Login to get access
Metadata
Title
IL-2-mediated augmentation of NK-cell activity and activation antigen expression on NK- and T-cell subsets in patients with metastatic melanoma treated with interferon-α and DTIC
Authors
Gordana Konjević
Viktor Jović
Vladimir Jurišić
Siniša Radulović
Svetislav Jelić
Ivan Spužić
Publication date
01-11-2003
Publisher
Kluwer Academic Publishers
Published in
Clinical & Experimental Metastasis / Issue 7/2003
Print ISSN: 0262-0898
Electronic ISSN: 1573-7276
DOI
https://doi.org/10.1023/A:1027387930868

Other articles of this Issue 7/2003

Clinical & Experimental Metastasis 7/2003 Go to the issue

OriginalPaper

Inhibitory effect of antisense aminopeptidase N (APN/CD13) cDNA transfection on the invasive potential of osteosarcoma cells

OriginalPaper

Expression of the 67 kDa laminin receptor and the α6 integrin subunit in serous ovarian carcinoma

OriginalPaper

Increased metastatic potential in human prostate carcinoma cells by overexpression of arachidonate 12-lipoxygenase

OriginalPaper

Matrix metalloproteinases (MMP), EMMPRIN (extracellular matrix metalloproteinase inducer) and mitogen-activated protein kinases (MAPK): Co-expression in metastatic serous ovarian carcinoma

OriginalPaper

Real-time imaging of individual fluorescent-protein color-coded metastatic colonies in vivo

OriginalPaper

Biological properties and gene expression associated with metastatic potential of human osteosarcoma
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits